RARE's IND for UX016, a novel sialic acid prodrug targeting GNEM, a rare muscle disease, gets accepted by the FDA. The ...

Myopathy describes disorders of the muscles that cause them to function less effectively. Myopathies can be inherited or acquired, and the symptoms may be present from birth or develop later on.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for UX016, an investigational ...

Myopathies are a group of disorders that are characterized by a primary structural or functional impairment of the skeletal muscle. These diseases usually affect muscles without involving the nervous ...

The diagnosis is rare, but devastating -- children with congenital muscle disorders often never learn to walk. Until now, there was no chance of recovery, but researchers are now presenting a possible ...

Myopathy is a common term for a muscle disease that is unrelated to any disorder of innervation or neuromuscular junction, with a wide range of possible etiologies. Practically all types of myopathy ...

A clinical trial has led to the approval of a treatment for patients with a rare, muscle-weakening disease called GNE myopathy. In order to treat an underserved population of patients with a rare ...

This page lists all known medications that could potentially lead to 'Myopathy' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Background: Many patients taking statins often complain of muscle pain and weakness. The extent to which muscle pain reflects muscle injury is unknown. Methods: We obtained biopsy samples from the ...

This section presents medications that are known to potentially lead to 'Proximal myopathy' as a side effect. It's important to note that mild side effects are quite common with medications. Please be ...